CME / CME Group Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 25, 2025 (July 25, 2025) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commis

Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025 •Record revenue of $1.7 billion, up 10%

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 23, 2025 CME GROUP INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 23, 2025 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 9, 2025 (May 8, 2025) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Credit Agreement, dated as of April 23, 2025, among CME Group Inc., certain lenders, agents, arrangers, bookrunners, and Bank of America, N.A., as Administrative Agent.

exhibit101cmegroupamende EXHIBIT 10.1 2022076716 CUSIP Numbers: Deal: 12572RAZ6 MC Revolver: 12572RBA0 USD Revolver: 12572RBB8 $2,250,000,000 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 23, 2025 among CME GROUP INC., as Borrower, THE LENDERS PARTY HERETO, and BANK OF AMERICA, N.A, as Administrative Agent, BARCLAYS BANK PLC, BMO BANK N.A., CITIBANK, N.A., WELLS FARGO BANK, NATIONAL ASSO

Amendment No. 10 to Credit Agreement, dated as of April 23, 2025, among Chicago Mercantile Exchange Inc., Bank of America, N.A., in its capacity as administrative agent, Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent and the banks party thereto. The Amended Credit Agreement as amended through Amendment No. 10, among Chicago Mercantile Exchange Inc., each of the banks party thereto, Bank of America, N.A., in its capacity as administrative agent, and Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, is attached as Annex A to Amendment No. 10 (incorporated by reference to Exhibit 10.2 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on April 25, 2025).

EXECUTION VERSION 2024509765 ANNEX A TO AMENDMENT NO. 10 TO CREDIT AGREEMENT AMENDED CREDIT AGREEMENT as amended as of November 1, 2018, as further amended as of May 1, 2019, as further amended as of April 29, 2020, as further amended as of February 5, 2021, as further amended as of April 28, 2021, as further amended as of April 27, 2022, as further amended as of April 26, 2023, as further amended

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 25, 2025 ( April 23, 2025) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Com

Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2025 •Record revenue of $1.6 billion, up 10%

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 23, 2025 CME GROUP INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 23, 2025 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2025 CME GROUP INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2025 CME GROUP INC.

S&P Global and CME Group to sell OSTTRA to KKR for $3.1 billion

EX-99.1 Exhibit 99.1 S&P Global and CME Group to sell OSTTRA to KKR for $3.1 billion New York, NY, April 14, 2025—S&P Global and CME Group today announced the signing of a definitive agreement to sell OSTTRA, a leading provider of post-trade solutions for the global OTC market, to investment funds managed by KKR, a leading global investment firm. The terms of the deal for OSTTRA equaled total ente

Hello, My name is Will Hobert and I am a candidate for a Class B-1 director on the CME Group Board of Directors. I was first elected to the CME Group Board in 2015. Currently, I co-chair the Clearing House Risk Committee (CHRC) and Chair the Interest

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  Definit

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a con

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  Definit

ARS

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2025 CME GROUP INC. (Exact name of registrant as specified in its charter) Delaware 001-31553 36-4459170 (State or other jurisdiction of incorporation) (Commission File Numb

Eleventh Supplemental Indenture (including the form of 4.400% Notes due 2030), dated as of March 10, 2025, between CME Group Inc. and U.S. Bank Trust Company, National Association.

Exhibit 4.2 Execution Version CME GROUP INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee Eleventh Supplemental Indenture Dated as of March 10, 2025 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a series of Securities designated 4.400% Notes due 2030 ELEVENTH SUPPLEMENTAL INDENTURE, dated as of March 10, 2025 (herein called the “Eleventh Supplemental Indenture”

Underwriting Agreement, dated March 3, 2025, between CME Group Inc. and Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Exhibit 1.1 Execution Version CME GROUP INC. $750,000,000 4.400% Notes due 2030 UNDERWRITING AGREEMENT March 3, 2025 Underwriting Agreement March 3, 2025 Barclays Capital Inc. J.P. Morgan Securities LLC Wells Fargo Securities, LLC As Representatives of the several Underwriters c/o Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 J.P. Morgan Securities LLC 383 Madison Avenue New Yo

Calculation of Filing Fee Table 424(b)(5) (1) (Form Type) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Re gi stered Securities

EXHIBIT 107 Calculation of Filing Fee Table 424(b)(5) (1) (Form Type) CME GROUP INC.

CME Group Inc. 4.400% Notes due 2030

Filed Pursuant to Rule 424(b)(5) Registration No. 333-285481 Prospectus Supplement (To Prospectus dated March 3, 2025) $750,000,000 CME Group Inc. 4.400% Notes due 2030 We are offering $750,000,000 of our 4.400% notes due 2030 (the “notes”). The notes will mature on March 15, 2030 and will bear interest at a rate of 4.400% per year. Interest on the notes will be payable semi-annually in arrears on

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2025 CME GROUP INC. (Exact name of registrant as specified in its charter) Delaware 001-31553 36-4459170 (State or other jurisdiction of incorporation) (Commission File Numbe

Filing Fee Table.**

Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities  Security  Type Security Class Title (1) Fee  Calculation  or Carry Forward Rule (2) Amount  Registered (3)   Proposed  Maximum  Offering Price Per Unit (3) Maximum Aggregate Offering Price (3) Fee  Rate (2)  

Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of U.S. Bank Trust Company, National Association, as trustee under the indenture.**

Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

SUBJECT TO COMPLETION PRELIMINARY PROSPECTUS SUPPLEMENT DATED MARCH 3, 2025

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-285481 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where

Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of U.S. Bank Trust Company, National Association, as trustee under the subordinated indenture.**

Exhibit 25.2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

As filed with the Securities and Exchange Commission on March 3, 2025

Table of Contents As filed with the Securities and Exchange Commission on March 3, 2025 Registration No.

4.400% Notes due 2030 (the “Notes”) Issuer: CME Group Inc. Security Type: SEC Registered Senior Unsecured Notes Trade Date: March 3, 2025 Settlement Date**: March 10, 2025 (T+5) Principal Amount: $750,000,000 Maturity Date: March 15, 2030 Interest Ra

Free Writing Prospectus Filed pursuant to Rule 433 Registration No. 333-285481 Term Sheet (To preliminary prospectus supplement, dated March 3, 2025, and prospectus, dated March 3, 2025) $750,000,000 4.400% Notes due 2030 (the “Notes”) Issuer: CME Group Inc. Security Type: SEC Registered Senior Unsecured Notes Trade Date: March 3, 2025 Settlement Date**: March 10, 2025 (T+5) Principal Amount: $750

List of Subsidiaries of CME Group Inc.

Exhibit 21.1 CME Group Subsidiaries Name of Subsidiary* Jurisdiction of Incorporation or Organization Board of Trade of the City of Chicago, Inc. Delaware BrokerTec Americas LLC Delaware BrokerTec Europe Limited United Kingdom BrokerTec Holdings Inc. Delaware Chicago Mercantile Exchange Inc. Delaware Chicago Mercantile Exchange Korea Inc. Republic of Korea CME Amsterdam B.V. Netherlands CME Consul

CME Group Inc. Personal Trading Policy.

Exhibit 19.1 FINAL CME GROUP PUBLIC LEADING WITH CONVICTION AND INTEGRITY PERSONAL TRADING POLICY CME Group Policy Document No. and Version No: 0004 Version 13.0 Policy Document Issued By: Global Corporate Compliance & Ethics Team Policy Document Owner Information: Corporate Compliance Date Policy Document Originally Issued: 2002 Date Policy Document Last Revised: February 2025 PURPOSE & STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-31553 CME GROUP INC. (Exact name of registrant as speci

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 12, 2025 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No

- more -

EX-99.1 2 exhibit991123124.htm EX-99.1 Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 CME-G [email protected] cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports All-Time Record Annual Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for 2024 •Record revenue of $

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) December 11, 2024 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No

CHICAGO, Dec. 5, 2024 – CME Group, the world’s leading derivatives marketplace, announced that its Board of Directors approved two initiatives to return capital to shareholders.

Exhibit 99.1 Media Contacts Investor Contact N E W S  R E L E A S E Media Contacts Laurie Bischel, 312.648.8698 [email protected] www.cmegroup.mediaroom.com   Investor Contact [email protected] CME-G FOR IMMEDIATE RELEASE CME Group Announces $2.1B Annual Variable Dividend and $3B Share Repurchase Program CHICAGO, Dec. 5, 2024 – CME Group, the world’s leading derivatives marketplace, announced

Regulation FD Disclosure, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2024 CME GROUP INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 7, 2024 (November 6, 2024) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (

Media Contacts

Exhibit 99.1 NEWS RELEASE Media Contacts Investor Contact Laurie Bischel, 312.648.8698 Adam Minick,312.340.8365 [email protected] [email protected] www.cmegroup.mediaroom.com CME-G FOR IMMEDIATE RELEASE CME Group Announces Employment Agreement Extension for Chairman and Chief Executive Officer Terry Duffy • Chief Financial Officer Lynne Fitzpatrick Appointed to President and CFO • Suzanne Spr

Amended and Restated Agreement, effective as of November 6, 2024, between CME Group Inc. and Terrence A. Duffy.

Exhibit 10.1 EXECUTION COPY AMENDED AND RESTATED AGREEMENT THIS AMENDED AND RESTATED AGREEMENT (this “Agreement”), effective as of November 6, 2024 (the “2024 Restatement Effective Date”) by and between CME Group Inc. (“Employer” or “CME”), a Delaware corporation, having its principal place of business at 20 South Wacker Drive, Chicago, Illinois, and Terrence A. Duffy (“Executive”). R E C I T A L

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 23, 2024 CME GROUP INC. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 23, 2024 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.

Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q3 2024 •Record revenue of $1.6 billion •Record

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports All-Time Record Revenue of $1.5 Billion for Q2 2024 •Record quarterly adjusted net income and earnings per share •Highest Q2 average daily volume (ADV) in c

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 24, 2024 CME GROUP INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 24, 2024 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

# # #

EX-99.1 Exhibit 99.1 News Release Media Contacts Investor Contact Laurie Bischel, 312.292.1937 [email protected] [email protected] CME-G www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Appoints Mike Dennis as Global Head of Fixed Income CHICAGO, July 8, 2024 – CME Group, the world’s leading derivatives marketplace, today announced the appointment of Mike Dennis as Global Head, Fixe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 8, 2024 (July 8, 2024) CME GR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 8, 2024 (July 8, 2024) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commissi

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 13, 2024 (May 9, 2024) CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Amendment No. 8 to Credit Agreement, dated as of April 24, 2024, among Chicago Mercantile Exchange Inc., Bank of America, N.A., in its capacity as administrative agent, Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, and the banks party thereto. The Amended Credit Agreement, as amended through Amendment No. 8, among Chicago Mercantile Exchange Inc., each of banks from time to time party thereto, Bank of America, N.A., in its capacity as administrative agent, and Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, is attached as Annex A to Amendment No. 8 (incorporated by reference to Exhibit 10.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on April 25, 2024).

Exhibit 10.1 EXECUTION VERSION AMENDMENT NO. 8 TO CREDIT AGREEMENT (2024 FACILITY RENEWAL) This AMENDMENT NO. 8 TO CREDIT AGREEMENT (this “Amendment”) dated as of April 24, 2024, is among CHICAGO MERCANTILE EXCHANGE INC., a Delaware corporation (the “Company”), BANK OF AMERICA, N.A., in its capacity as administrative agent for the Banks (as defined in the Credit Agreement described below) (in such

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 25, 2024 (April 24, 2024) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Comm

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 24, 2024 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.)

Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports First-Quarter 2024 Financial Results CHICAGO, April 24, 2024 - CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2024.

Hello, My name is Will Hobert and I am a candidate for a Class B-1 seat on the CME Group Board of Directors. I was first elected to the CME Group Board in 2015. Currently, I co-chair the Clearing House Risk Committee (CHRC) and Chair the Interest Rat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  Definit

Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a con

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  Definit

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

CME Group Inc. Fourth Amended and Restated Omnibus Stock Plan, amended and restated as of March 1, 2024 (incorporated by reference to Exhibit 10.1 to CME Group Inc.’s Form 8-K, filed with the SEC on March 7, 2024).

Exhibit 10.1 CME GROUP INC. FOURTH AMENDED AND RESTATED OMNIBUS STOCK PLAN (Effective March 1, 2024) ARTICLE 1 EFFECTIVE DATE AND PURPOSE 1.1 Effective Date. The Plan was originally adopted as the Chicago Mercantile Exchange Omnibus Stock Plan effective as of February 7, 2000, and was amended and restated from time to time thereafter and is hereby further amended and restated as of March 1, 2024 (

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) March 7, 2024 (March 4, 2024) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-31553 CME GROUP INC. (Exact name of registrant as speci

List of Subsidiaries of CME Group Inc.

Exhibit 21.1 CME Group Subsidiaries Name of Subsidiary* Jurisdiction of Incorporation or Organization Board of Trade of the City of Chicago, Inc. Delaware BrokerTec Americas LLC Delaware BrokerTec Europe Limited United Kingdom BrokerTec Holdings Inc. Delaware Chicago Mercantile Exchange Inc. Delaware Chicago Mercantile Exchange Korea Inc. Republic of Korea CME Amsterdam B.V. Netherlands CME Consul

CME Group Inc. Compensation Recoupment Policy for Executive Officers effective as of October 2, 2023.

EXHIBIT 97.1 CME GROUP INC. COMPENSATION RECOUPMENT POLICY FOR EXECUTIVE OFFICERS The Compensation Committee (“Committee”) of the Board of Directors of CME Group Inc. (the “Company”) adopts this Compensation Recoupment Policy for Executive Officers (“Policy”) effective as of October 2, 2023 (“Effective Date”). This Policy is designed to comply with Section 10D of the Securities Exchange Act of 193

Third Amendment to Chicago Mercantile Exchange Inc. Senior Management Supplemental Deferred Savings Plan, as of December 6, 2023 (filed herewith). Second Amendment to Chicago Mercantile Exchange Inc. Senior Management Supplemental Deferred Savings Plan, as of June 1, 2023 (filed herewith). First Amendment to Chicago Mercantile Exchange Inc. Senior Management Supplemental Deferred Savings Plan, as of January 1, 2020 (filed herewith). Chicago Mercantile Exchange Inc. Senior Management Supplemental Deferred Savings Plan (SMSDSP), Amended and Restated as of January 1, 2017 (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 2, 2017).

Exhibit 10.5 FIRST AMENDMENT TO CHICAGO MERCANTILE EXCHANGE INC. SENIOR MANAGEMENT SUPPLEMENTAL DEFERRED SAVINGS PLAN The Chicago Mercantile Exchange Inc. Senior Management Supplemental Deferred Savings Plan (the “Plan”) is amended, effective January 1, 2020, as follows: 1. NEX Services North America, LLC, BrokerTec Americas LLC, EBS Dealing Resources, Inc., Traiana, Inc. and TriOptima North Ameri

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 14, 2024 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No

- more -

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 CME-G [email protected] cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Fourth-Quarter and Full-Year 2023 Financial Results •Strongest Year in Company History with Interest Rate Products Driving Record Annual Average Daily Volume and Revenue CHICAGO,

CME / CME Group Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: CME Group Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 12572Q105 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed

Amended and Restated Agreement, effective as of December 6, 2023, between CME Group Inc. and Terrence A. Duffy.

Exhibit 10.1 AMENDED AND RESTATED AGREEMENT THIS AMENDED AND RESTATED AGREEMENT, effective as of December 6, 2023 (the “2023 Restatement Effective Date”) by and between CME Group Inc. (“Employer” or “CME”), a Delaware corporation, having its principal place of business at 20 South Wacker Drive, Chicago, Illinois, and Terrence A. Duffy (“Executive”). R E C I T A L S: WHEREAS, Employer wishes to con

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) (December 6, 2023) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File N

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 29, 2023 (November 29, 2023) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 13, 2023 (November 7, 202

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 13, 2023 (November 7, 2023) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation)

Retirement Agreement, effective as of November 8, 2023, between Chicago Mercantile Exchange Inc. and John Pietrowicz.

EX-10.1 Exhibit 10.1 November 8, 2023 Retirement Agreement John Pietrowicz [Address Removed] Dear John: This letter agreement (“Agreement”) will set forth our mutual understanding as to the rights and obligations of you and Chicago Mercantile Exchange Inc. (the “Company”) in connection with your retirement. In consideration of the mutual promises and agreements set forth below, you and the Company

CME Group Inc. Annual Incentive Plan, as amended and restated effective as of October 2, 2023 (incorporated by reference to Exhibit 10.2 to CME Group Inc.’s Form 8-K, filed with the SEC on November 13, 2023).

EX-10.2 Exhibit 10.2 CME GROUP INC. ANNUAL INCENTIVE PLAN (As Amended and Restated effective October 2, 2023) 1. Purpose. The purpose of the CME Group Inc. Annual Incentive Plan is to align the interests of Company management with those of the shareholders of the Company by encouraging management to achieve goals intended to increase shareholder value. 2. Definitions. The following terms, as used

Form of Equity Grant Letter for Annual Grant of Performance Shares (incorporated by reference to Exhibit 10.1(1) to CME Group Inc.’s Form 10-Q, filed with the SEC on November 1, 2023)

Exhibit 10.1 Name: Department: Division: Congratulations! We are pleased to provide you with a long-term incentive opportunity under the CME Group Inc. Third Amended and Restated Omnibus Stock Plan (the “Plan”). This long-term incentive opportunity is in recognition of the anticipated positive impact you will make toward the future success of the company. Your grant provides you with the opportuni

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n

Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G www.cmegroup.com/media-room.html

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G www.cmegroup.com/media-room.html FOR IMMEDIATE RELEASE CME Group Inc. Reports Third-Quarter 2023 Financial Results CHICAGO, October 25, 2023 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quart

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 25, 2023 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) September 21, 2023 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G www.cmegroup.com/media-room.html

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 [email protected] [email protected] CME-G www.cmegroup.com/media-room.html FOR IMMEDIATE RELEASE CME Group Inc. Reports Second-Quarter 2023 Financial Results •Double-digit growth in revenue and adjusted earnings per share CHICAGO, July 26, 2023 - CME Group Inc. (NAS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 26, 2023 CME GROUP INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 26, 2023 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 9, 2023 (May 4, 2023) CME GROU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 9, 2023 (May 4, 2023) CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 28, 2023 (April 26, 2023) CM

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 28, 2023 (April 26, 2023) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Comm

Amendment No. 7 to Credit Agreement, dated as of April 26, 2023, among Chicago Mercantile Exchange Inc., Bank of America, N.A., in its capacity as administrative agent, Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, and the banks party thereto. The Amended Credit Agreement, as amended through Amendment No. 7, among Chicago Mercantile Exchange Inc., each of the banks party thereto, Bank of America, N.A., in its capacity as administrative agent, and Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, is attached as Annex A to Amendment No. 7 (incorporated by reference to Exhibit 10.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on April 28, 2023).

EX-10.1 Exhibit 10.1 AMENDMENT NO. 7 TO CREDIT AGREEMENT (2023 FACILITY RENEWAL) This AMENDMENT NO. 7 TO CREDIT AGREEMENT (this “Amendment”) dated as of April 26, 2023, is among CHICAGO MERCANTILE EXCHANGE INC., a Delaware corporation (the “Company”), BANK OF AMERICA, N.A., in its capacity as administrative agent for the Banks (as defined in the Credit Agreement described below) (in such capacity,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 26, 2023 CME GROUP INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 26, 2023 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.)

Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.com/media-room.html

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.com/media-room.html FOR IMMEDIATE RELEASE CME Group Inc. Reports First-Quarter 2023 Financial Results •Highest quarterly adjusted net income and adjusted earnings per share ever CHICAGO, April 26, 2023 - CME Group Inc. (NASDAQ: CME) t

CME GROUP INC. 20 SOUTH WACKER DRIVE CHICAGO, IL 60606 SUPPLEMENT TO THE PROXY STATEMENT FOR THE 2023 ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 4, 2023 The following information relates to the proxy statement of CME Group Inc., dated March 17,

2023 CME Group Proxy Supplement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Retirement Agreement, effective as of March 29, 2023, between Chicago Mercantile Exchange Inc. and Sean Tully.

EX-10.1 Exhibit 10.1 March 29, 2023 Retirement Agreement Sean Tully [Address Removed] Dear Sean: This letter agreement (“Agreement”) will set forth our mutual understanding as to the rights and obligations of you and Chicago Mercantile Exchange Inc. (the “Company”) in connection with your retirement. In consideration of the mutual promises and agreements set forth below, you and the Company agree

# # #

EX-99.1 Exhibit 99.1 Media Contacts Investor Contact Timothy Barello, 212.299.2256 [email protected] [email protected] CME-G www.cmegroup.com/media-room.html FOR IMMEDIATE RELEASE CME Group Appoints Tim McCourt as Global Head of Financial & OTC Products • Sean Tully to Retire in June CHICAGO, March 30, 2023 – CME Group, the world’s leading derivatives marketplace, today announced that it has

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) March 30, 2023 (March 29, 2023) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Comm

Hello, My name is Will Hobert and I am a candidate for a Class B-1 seat on the CME Group Board of Directors. I was first elected to the CME Group Board in 2015. Currently, I co-chair the Clearing House Risk Committee (CHRC) and Chair the Interest Rat

2023 Class B Nominee Campaign Letters UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Your Vote Counts! Vote in Person at the Meeting* May 4, 2023 10:00 AM CT CME Group’s headquarters Auditorium 20 South Wacker Drive Chicago, IL *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, yo

CME Group Inc. 2023 Notice UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only (as permitted by

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

CME Group Inc. Severance Plan, as amended and restated, effective March 7, 2023 (incorporated by reference to Exhibit 10.1 to CME Group Inc.’s Form 8-K, filed with the SEC on March 10, 2023).

EX-10.1 Exhibit 10.1 CME GROUP INC. SEVERANCE PLAN (As amended and restated effective March 7, 2023) March 7, 2023 TABLE OF CONTENTS Page I. Purpose, Intent, and Effective Date 1 II. Definition 1 2.1 “Administrator” 1 2.2 “Cause” 1 2.3 “Code 1 2.4 “Continuation Coverage” 1 2.5 “Controlled Group” 1 2.6 “Employee” 2 2.7 “Employer” 2 2.8 “Involuntary Termination” 2 2.9 “Qualifying Performance Termina

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) March 10, 2023 (March 6, 2023) CME

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) March 10, 2023 (March 6, 2023) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 28, 2023 (February 23, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 28, 2023 (February 23, 2023) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation)

List of Subsidiaries of CME Group Inc.

Exhibit 21.1 CME Group Subsidiaries Name of Subsidiary* Jurisdiction of Incorporation or Organization Board of Trade of the City of Chicago, Inc. Delaware BrokerTec Americas LLC Delaware BrokerTec Europe Limited United Kingdom BrokerTec Holdings Inc. Delaware C-B-T Corporation Delaware Chicago Mercantile Exchange Inc. Delaware Chicago Mercantile Exchange Korea Inc. Republic of Korea CME Amsterdam

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-31553 CME GROUP INC. (Exact name of registrant as speci

CME / CME Group Inc / Capital World Investors - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10 )* CME Group Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 12572Q105 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des

CME / CME Group Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0604-cmegroupinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: CME Group Inc. Title of Class of Securities: Common Stock CUSIP Number: 12572Q105 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 8, 2023 CME GROUP INC. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 8, 2023 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (I

- more -

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 Adam Minick, 312.340.8365 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.com/media-room.html FOR IMMEDIATE RELEASE CME Group Inc. Reports Fourth-Quarter and Full-Year 2022 Financial Results CHICAGO, February 8, 2023 - CME Group Inc. (NASDAQ: CME) today reported financial results for the fourth quarter and

February 3, 2023 To: Our Class B-1, Class B-2 and Class B-3 Shareholders As recently announced, CME Group’s Nominating and Governance Committee completed their interview and selection processes for nominees for election to our Board of Directors at t

2023 Letter Announcing Class B Nominees UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Seventeenth Amended and Restated Bylaws of CME Group Inc. (incorporated by reference to Exhibit 3.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on December 9, 2022).

EX-3.1 Exhibit 3.1 SEVENTEENTH AMENDED AND RESTATED BYLAWS OF CME GROUP INC. Approved as of December 7, 2022 ARTICLE I SHAREHOLDERS’ MEETINGS Section 1.1 Annual Meetings. (a) The annual meetings of shareholders shall be held on such date, at such time and at such place, either within or without the state of Delaware, as shall be designated from time to time by the Board of Directors and stated in

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) December 9, 2022 (December 7, 2022) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 29, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 - OR - ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 26, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.

Media contact Investor contact Timothy Barello, 212.299.2256 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Third-Quarter 2022 Financial Results CHICAGO, October 26, 2022 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2022. The company rep

* * *

CORRESP 1 filename1.htm September 30, 2022 U.S. Securities and Exchange Commission Division of Corporate Finance Disclosure Review Program 100 F Street, N.E. Washington, D.C. 20549 ATTN: Amanda Ravitz Barbara Jacobs Filed Via EDGAR as Correspondence RE: CME Group Inc. Definitive Proxy Statement on Schedule 14A Filed March 17, 2022 File No. 001-31553 This letter sets forth the responses of CME Grou

License Agreement, dated June 29, 2012, between Standard & Poor’s Financial Services LLC and Chicago Mercantile Exchange Inc. (incorporated by reference to Exhibit 10.5 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 3, 2022).

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

CME Group Inc. Third Amended and Restated Omnibus Stock Plan, amended and restated as of May 4, 2022 (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 10-Q, filed with the SEC on August 3, 2022).

CME GROUP INC. THIRD AMENDED AND RESTATED OMNIBUS STOCK PLAN (Effective May 4, 2022) ARTICLE 1 EFFECTIVE DATE AND PURPOSE 1.1 Effective Date. The Plan was originally adopted as the Chicago Mercantile Exchange Omnibus Stock Plan effective as of February 7, 2000, and was amended and restated from time to time thereafter and is hereby further amended and restated as of May4, 2022 (the “Effective Date

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 27, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

Media contact Investor contact Timothy Barello, 212.299.2256 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Timothy Barello, 212.299.2256 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Second-Quarter 2022 Financial Results CHICAGO, July 27, 2022 - CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2022. The company repo

CME Group Inc. Employee Stock Purchase Plan, amended and restated as of May 4, 2022 (incorporated by reference to Exhibit 99.2 to CME Group Inc.’s Form S-8, filed with the SEC on June 9, 2022).

Exhibit 99.2 AMENDED AND RESTATED CME GROUP INC. EMPLOYEE STOCK PURCHASE PLAN (amended and restated as of May 4, 2022) 1. Effective Date. The CME Group Inc. Employee Stock Purchase Plan (the ?Plan?) was originally adopted as the Chicago Mercantile Exchange Holdings Inc. Employee Stock Purchase Plan effective as of April 27, 2005, and was amended and restated from time to time thereafter and is her

As filed with the Securities and Exchange Commission on June 9, 2022.

As filed with the Securities and Exchange Commission on June 9, 2022. Registration No. 333- United States Securities and Exchange Commission Washington, DC 20549 Form S-8 Registration Statement Under the Securities Act of 1933 CME Group Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 36-4459170 (I.R.S. Employer Ide

Filing fee table

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) CME Group Inc. (Exact Name of Registrant as Specified in its Charter) TABLE 1?NEWLY REGISTERED SECURITIES Security type Security class title Fee calculation rule Amount registered Proposed maximum offering price per unit Maximum aggregate offering price Fee rate Amount of registration fee Equity Class A Common Stock, par value $.01

CME Group Inc. Director Stock Plan, amended and restated as of May 4, 2022 (incorporated by reference to Exhibit 99.1 to CME Group Inc.’s Form S-8, filed with the SEC on June 9, 2022).

Exhibit 99.1 CME GROUP INC. DIRECTOR STOCK PLAN Amended and Restated Effective May 4, 2022 1. Purpose. The purpose of the CME Group Inc. Director Stock Plan (the ?Plan?) is to provide CME Group Inc. (the ?Company?) with an effective means of attracting, retaining, and motivating non-employee directors of the Company and to further align their interests with those of the Company?s shareholders by p

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 6, 2022 (May 4, 2022) CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Amendment No. 6 to Credit Agreement, dated as of April 27, 2022, among Chicago Mercantile Exchange Inc., Bank of America, N.A., in its capacity as administrative agent, Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, and the banks party thereto. The Amended Credit Agreement, as amended through Amendment No. 6, among Chicago Mercantile Exchange Inc., each of the banks party thereto, Bank of America, N.A., in its capacity as administrative agent, and Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, is attached as Annex A to Amendment No. 6 (incorporated by reference to Exhibit 10.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on April 28, 2022).

Exhibit 10.1 EXECUTION VERSION AMENDMENT NO. 6 TO CREDIT AGREEMENT (2022 FACILITY RENEWAL) This AMENDMENT NO. 6 TO CREDIT AGREEMENT (this ?Amendment?) dated as of April 27, 2022, is among CHICAGO MERCANTILE EXCHANGE INC., a Delaware corporation (the ?Company?), BANK OF AMERICA, N.A., in its capacity as administrative agent for the Banks (as defined in the Credit Agreement described below) (in such

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 28, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.)

Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports First-Quarter 2022 Financial Results CHICAGO, April 27, 2022 - CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2022. The company reported

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 27, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.)

SUPPLEMENT TO DEFINITIVE PROXY STATEMENT RELATING TO THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON WEDNESDAY, MAY 4, 2022 CME Group Inc. (“CME Group” or the “Company”) filed its proxy statement relating to its annual meeting on March 17, 2022. Ms.

dutra UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  D

SUPPLEMENT TO DEFINITIVE PROXY STATEMENT RELATING TO THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON WEDNESDAY, MAY 4, 2022 CME Group Inc. (“CME Group” or the “Company”) filed its proxy statement relating to its annual meeting on March 17, 2022. Ms.

DEFA14A 1 dutraadditionalfiling.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 12, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.)

Retirement Agreement, effective as of April 12, 2022, between Chicago Mercantile Exchange Inc. and Kevin Kometer.

Exhibit 10.1 April 11, 2022 Retirement Agreement Kevin Kometer [Personal Address Redacted] Dear Kevin: This letter agreement (?Agreement?) will set forth our mutual understanding as to the rights and obligations of you and Chicago Mercantile Exchange Inc. (the ?Company?) in connection with your retirement. In consideration of the mutual promises and agreements set forth below, you and the Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registran

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definit

Your Vote Counts! CME GROUP INC. 2022 Annual Meeting Vote by May 3, 2022 10:59 PM CT You invested in CME GROUP INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice rega

DEFA14A 1 cmegroupinc2022notice.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEF 14A 1 cmegroupinc2022proxystatem.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2022 CME GROUP INC. (Exact name of registrant as specified in its charter) Delaware 001-31553 36-4459170 (State or other jurisdiction of incorporation) (Commission File Numbe

Tenth Supplemental Indenture (including the form of 2.650% Notes due 2032), dated as of March 8, 2022, between CME Group Inc. and U.S. Bank Trust Company, National Association (incorporated by reference to Exhibit 4.2 to CME Group Inc.’s Current Report on Form 8-K filed with the SEC on March 8, 2022).

Exhibit 4.2 Execution Version CME GROUP INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee Tenth Supplemental Indenture Dated as of March 8, 2022 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a series of Securities designated 2.650% Notes due 2032 TENTH SUPPLEMENTAL INDENTURE, dated as of March 8, 2022 (herein called the ?Tenth Supplemental Indenture?), between

CME Group Inc. 2.650% Notes due 2032

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-263130 Prospectus Supplement (To Prospectus dated March 1, 2022) $750,000,000 CME Group Inc. 2.650% Notes due 2032 We are offering $750,000,000 of our 2.650% notes due 2032 (the ?notes?). The notes will mature on March 15, 2032 and will bear interest at a rate of 2.650% per year. Interest on the notes will be payable semi-annu

Calculation of Filing Fee Table FORM S-3 (Form Type) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered

EXHIBIT 107 Calculation of Filing Fee Table FORM S-3 (Form Type) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities

Underwriting Agreement, dated March 1, 2022, between CME Group Inc. and Barclays Capital Inc. and BofA Securities, Inc., as representatives of the underwriters named therein.

EX-1.1 2 d111690dex11.htm EX-1.1 Exhibit 1.1 Execution Version CME GROUP INC. $750,000,000 2.650% Notes due 2032 UNDERWRITING AGREEMENT March 1, 2022 Underwriting Agreement March 1, 2022 Barclays Capital Inc. BofA Securities, Inc. As Representatives of the several Underwriters c/o Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 BofA Securities, Inc. One Bryant Park New York, New

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2022 CME GROUP INC. (Exact name of registrant as specified in its charter) Delaware 001-31553 36-4459170 (State or other jurisdiction of incorporation) (Commission File Numbe

2.650% Notes due 2032 Issuer: CME Group Inc. Security Type: SEC Registered Senior Unsecured Notes Trade Date: March 1, 2022 Settlement Date: March 8, 2022 (T+5) Principal Amount: $750,000,000 Maturity Date: March 15, 2032 Interest Rate Per Annum: 2.6

Free Writing Prospectus Filed pursuant to Rule 433 Registration No. 333-263130 Pricing Term Sheet (To preliminary prospectus supplement, dated March 1, 2022, and prospectus, dated March 1, 2022) $750,000,000 2.650% Notes due 2032 Issuer: CME Group Inc. Security Type: SEC Registered Senior Unsecured Notes Trade Date: March 1, 2022 Settlement Date: March 8, 2022 (T+5) Principal Amount: $750,000,000

SUBJECT TO COMPLETION PRELIMINARY PROSPECTUS SUPPLEMENT DATED MARCH 1, 2022

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-263130 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where

Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of U.S. Bank Trust Company, National Association, as trustee under the indenture.**

Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of U.S. Bank Trust Company, National Association, as trustee under the subordinated indenture.**

Exhibit 25.2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

As filed with the Securities and Exchange Commission on March 1, 2022

Table of Contents As filed with the Securities and Exchange Commission on March 1, 2022 Registration No.

Filing Fee Table.**

Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(1) Maximum Aggregate Offering Price(1) Fee Rate Amount of Registration Fee

Description of securities (incorporated by reference to Exhibit 4.11 to CME Group Inc's Form 10-K, filed with the SEC on February 2, 2022).

Exhibit 4.11 DESCRIPTION OF CAPITAL STOCK The following is a description of certain terms relating to our capital stock. The following description is a summary and is qualified in its entirety by reference to our certificate of incorporation, as amended (?Certificate of Incorporation), our bylaws, as amended (?Bylaws?) and the relevant provisions of Delaware law. As used in this ?Description of Ca

List of Subsidiaries of CME Group Inc.

Exhibit 21.1 CME Group Subsidiaries Name of Subsidiary* Jurisdiction of Incorporation or Organization Abide Financial DRSP Limited* United Kingdom Abide Financial Ltd* United Kingdom Abide Financial Repository Limited* United Kingdom Astley & Pearce Limited United Kingdom Board of Trade of the City of Chicago, Inc. Delaware BrokerTec Americas LLC Delaware BrokerTec Europe Limited United Kingdom Br

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-31553 CME GROUP INC. (Exact name of registrant as speci

Media Contacts Investor Contact Anita Liskey, 312.735.8012 John Peschier, 312.930.8491 Laurie Bischel, 312.292.1937 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media Contacts Investor Contact Anita Liskey, 312.735.8012 John Peschier, 312.930.8491 Laurie Bischel, 312.292.1937 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Announces Senior Leadership Changes CHICAGO, February 17, 2022 ? CME Group, the world?s leading derivatives marketplace, today announced changes to its management team structure to positio

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 16, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No

CME / CME Group Inc / Capital World Investors - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9 )* CME Group Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 12572Q105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 9, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (I

CME / CME Group Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: CME Group Inc. Title of Class of Securities: Common Stock CUSIP Number: 12572Q105 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule

- more -

Exhibit 99.1 Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results CHICAGO, February 9, 2022 - CME Group Inc. (NASDAQ: CME) today reported financial results for the fourth quarter and full yea

Amended and Restated Agreement, effective as of February 2, 2022, by and between CME Group Inc. and Terrence A. Duffy (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Current Report on Form 8-K, filed with the SEC on February 3, 2022).

EXHIBIT 10.1 AMENDED AND RESTATED AGREEMENT THIS AMENDED AND RESTATED AGREEMENT, effective as of February 2, 2022 (the ?2022 Restatement Effective Date?) by and between CME Group Inc. (?Employer? or ?CME?), a Delaware corporation, having its principal place of business at 20 South Wacker Drive, Chicago, Illinois, and Terrence A. Duffy (?Executive?). R E C I T A L S: WHEREAS, Employer wishes to con

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

DEFA14A 1 d588728ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ P

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 2, 2022 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2021 CME GROUP INC.

Credit Agreement, dated as of November 12, 2021, among CME Group Inc., certain lenders, agents, arrangers, bookrunners, and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Current Report on Form 8-K, filed with the SEC on November 16, 2021).

Exhibit 10.1 EXECUTION VERSION $2,250,000,000 CREDIT AGREEMENT Dated as of November 12, 2021 among CME GROUP INC., as Borrower, THE LENDERS PARTY HERETO, and BANK OF AMERICA, N.A, as Administrative Agent, BARCLAYS BANK PLC, BMO HARRIS BANK N.A., CITIBANK, N.A., WELLS FARGO BANK, NATIONAL ASSOCIATION, BANK OF CHINA, NEW YORK BRANCH, LLOYDS BANK CORPORATE MARKETS PLC, MUFG BANK, LTD. JPMORGAN CHASE

Certificate of Designations of Series G Non-Voting Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to CME Group Inc.'s Current Report on Form 8-K, filed with the SEC on November 4, 2021).

Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF SERIES G NON-VOTING CONVERTIBLE PREFERRED STOCK, PAR VALUE $.01 PER SHARE, OF CME GROUP INC. Pursuant to Section 151 of the General Corporation Law of the State of Delaware (as amended from time to time, the ?DGCL?), CME Group Inc., a corporation organized and existing under the laws of the State of Delaware (?CME Group?), in accordance with the provision

Fourth Amended and Restated Certificate of Incorporation of CME Group Inc., as amended (incorporated by reference to Exhibit 3.2 to CME Group Inc.'s Current Report on Form 8-K, filed with the SEC on November 4, 2021).

EX-3.2 3 d204323dex32.htm EX-3.2 Exhibit 3.2 FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CME GROUP INC. CME Group Inc. (hereinafter referred to as the “Corporation”), which was originally incorporated in the State of Delaware on August 2, 2001 under the name Chicago Mercantile Exchange Holdings Inc., hereby certifies that this Fourth Amended and Restated Certificate of Incorporatio

# # #

Exhibit 99.1 FOR IMMEDIATE RELEASE CME Group Signs 10-Year Partnership with Google Cloud to Transform Global Derivatives Markets Through Cloud Adoption Companies to co-innovate to deliver expanded access, new products, and more efficiencies for all market participants Google also makes $1B equity investment in CME Group CHICAGO and SUNNYVALE, Calif. ? November 4, 2021 ? CME Group and Google Cloud

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2021 CME GROUP INC.

Form of Equity Grant Letter for Annual Grant of Performance Shares (incorporated by reference to Exhibit 10.2 to CME Group Inc.'s Form 10-Q, filed with the SEC on November 3, 2021).

Exhibit 10.2 Name: Department: Division: Congratulations! We are pleased to provide you with a long-term incentive opportunity under the CME Group Inc. Second Amended and Restated Omnibus Stock Plan (the ?Plan?). This long-term incentive opportunity is in recognition of the anticipated positive impact you will make toward the future success of the company. Your grant provides you with the opportun

Form of Equity Grant Letter for Restricted Shares (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 10-Q, filed with the SEC on November 3, 2021).

EXHIBIT 10.1 Name: Department: Division: Congratulations! We are pleased to provide you with an equity grant under the CME Group Inc. Second Amended and Restated Omnibus Stock Plan (the ?Plan?). This equity grant is in recognition of the anticipated positive impact you will make toward the future success of CME Group. Your equity grant may enable you to acquire ownership in CME Group Inc., which i

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 - OR - ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 27, 2021 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.

Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Third-Quarter 2021 Financial Results CHICAGO, October 27, 2021 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2021. The company reporte

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 - OR - ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Amended and Restated Bylaws of CME Group Inc. (incorporated by reference to Exhibit 3.1 to CME Group Inc.’s

SIXTEENTH AMENDED AND RESTATED BYLAWS OF CME GROUP INC. Approved as of August 4, 2021 ARTICLE I SHAREHOLDERS? MEETINGS Section 1.1 Annual Meetings. (a)The annual meetings of shareholders shall be held on such date, at such time and at such place, either within or without the state of Delaware, as shall be designated from time to time by the Board of Directors and stated in the notice of the meetin

Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Second-Quarter 2021 Financial Results CHICAGO, July 28, 2021 - CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2021. The company reported

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 28, 2021 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 10, 2021 (May 5, 2021) CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission Fi

Amendment No. 4 to Credit Agreement and Bank Joinder Agreement, dated as of February 5, 2021, between Chicago Mercantile Exchange, Inc., certain lenders, Bank of America, N.A., as Administrative Agent and Citibank N.A. as Collateral Agent and Collateral Monitoring Agent. The Amended Credit Agreement, as amended as of February 5, 2021, between Chicago Mercantile Exchange Inc., certain lenders, Bank of America, N.A., as Administrative Agent and Citibank N.A. as Collateral Agent and Collateral Monitoring Agent is attached as Annex A to the Amendment.

EXECUTION VERSION AMENDMENT NO. 4 TO CREDIT AGREEMENT This AMENDMENT NO. 4 TO CREDIT AGREEMENT (this ?Amendment?) dated as of February 5, 2021, is among CHICAGO MERCANTILE EXCHANGE INC., a Delaware corporation (the ?Company?), BANK OF AMERICA, N.A., in its capacity as administrative agent for the Banks (as defined in the Credit Agreement described below) (in such capacity, the ?Administrative Agen

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 - OR - ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Amendment No. 5 to Credit Agreement, dated as of April 28, 2021, among Chicago Mercantile Exchange Inc., certain lenders, Bank of America, N.A., as Administrative Agent, and Citibank, N.A., as Collateral Agent and Collateral Monitoring Agent. The Amended Credit Agreement, as amended through Amendment No. 5, among Chicago Mercantile Exchange Inc., certain lenders, Bank of America, N.A., as Administrative Agent, and Citibank, N.A., as Collateral Agent and Collateral Monitoring Agent, is attached as Annex A to Amendment No. 5 (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Current Report on Form 8-K, filed with the SEC on April 29, 2021).

Exhibit 10.1 EXECUTION VERSION AMENDMENT NO. 5 TO CREDIT AGREEMENT This AMENDMENT NO. 5 TO CREDIT AGREEMENT (this ?Amendment?) dated as of April 28, 2021, is among CHICAGO MERCANTILE EXCHANGE INC., a Delaware corporation (the ?Company?), BANK OF AMERICA, N.A., in its capacity as administrative agent for the Banks (as defined in the Credit Agreement described below) (in such capacity, the ?Administ

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 28, 2021 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.)

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 28, 2021 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.)

Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports First-Quarter 2021 Financial Results CHICAGO, April 28, 2021 - CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2021. The company reported

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEUDLE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Definitive Proxy Statement

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definit

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-31553 CME GROUP INC. (Exact name of registrant as speci

Description of securities

Exhibit 4.11 DESCRIPTION OF CAPITAL STOCK The following is a description of our capital stock. The following description is a summary and is qualified in its entirety by reference to our certificate of incorporation, as amended (?Certificate of Incorporation), our bylaws, as amended (?Bylaws?) and the relevant provisions of Delaware law. As used in this ?Description of Capital Stock,? the terms ?C

List of Subsidiaries of CME Group Inc.

Exhibit 21.1 CME Group Subsidiaries Name of Subsidiary* Jurisdiction of Incorporation or Organization Abide Financial DRSP Limited United Kingdom Abide Financial Ltd United Kingdom Abide Financial Repository Limited United Kingdom Astley & Pearce Limited United Kingdom Board of Trade of the City of Chicago, Inc. Delaware BrokerTec Americas LLC Delaware BrokerTec Europe Limited United Kingdom Broke

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8 )* CME Group Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 12572Q105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul

- more -

Exhibit 99.1 Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Fourth-Quarter and Full-Year 2020 Financial Results CHICAGO, February 10, 2021 - CME Group Inc. (NASDAQ: CME) today reported financial results for the fourth quarter and full ye

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 10, 2021 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: CME Group Inc. Title of Class of Securities: Common Stock CUSIP Number: 12572Q105 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule

- DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 10, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n

Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Chris Grams, 312.930.3435 John Peschier, 312.930.8491 Laurie Bischel, 312.648.8698 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Third-Quarter 2020 Financial Results CHICAGO, October 28, 2020 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2020. The company reporte

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 28, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (I

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Second-Quarter 2020 Financial Results CHICAGO, July 29, 2020 - CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2020. The company reported r

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 29, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 6, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS Em

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 29, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS

Amendment No. 3 to Credit Agreement and Bank Joinder Agreement, dated as of April 29, 2020, between Chicago Mercantile Exchange, Inc., certain lenders, Bank of America, N.A., as Administrative Agent and Citibank N.A., as Collateral Agent and Collateral Monitoring Agent (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 8-K, filed with the SEC on April 30, 2020).

EX-10.1 EXHIBIT 10.1 EXECUTION VERSION AMENDMENT NO. 3 TO CREDIT AGREEMENT This AMENDMENT NO. 3 TO CREDIT AGREEMENT (this “Amendment”) dated as of April 29, 2020, is among CHICAGO MERCANTILE EXCHANGE INC., a Delaware corporation (the “Company”), BANK OF AMERICA, N.A., in its capacity as administrative agent for the Banks (as defined in the Credit Agreement described below) (in such capacity, the “

Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com

Exhibit 99.1 Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports First-Quarter 2020 Financial Results CHICAGO, April 29, 2020 - CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2020. The company reported re

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) April 29, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS

CME / CME Group, Inc. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

CME / CME Group, Inc. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

CME / CME Group, Inc. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) March 20, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS

# # #

EX-99.1 Exhibit 99.1 Media Contacts Investor Contact Laurie Bischel, 312.648.8698 John Peschier, 312.930.8491 Anita Liskey, 312.466.4613 CME-G [email protected] www.cmegroup.com/media-room.html FOR IMMEDIATE RELEASE CME Group Statement on Ronin, LLC CHICAGO, March 20, 2020 – CME Group today confirmed that, pursuant to its rules, CME Clearing auctioned off portfolios of Ronin, LLC. The auction proc

CME / CME Group, Inc. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

CME / CME Group, Inc. DEF 14A - - DEF 14A

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-31553 CME GROUP INC. (Exact name of registrant as speci

Description of securities

Exhibit 4.11 DESCRIPTION OF CAPITAL STOCK The following is a description of our capital stock. The following description is a summary and is qualified in its entirety by reference to our certificate of incorporation, as amended (“Certificate of Incorporation), our bylaws, as amended (“Bylaws”) and the relevant provisions of Delaware law. As used in this “Description of Capital Stock,” the terms “C

List of Subsidiaries of CME Group Inc.

Exhibit 21.1 CME Group Subsidiaries Name of Subsidiary* Jurisdiction of Incorporation or Organization Abide Financial DRSP Limited United Kingdom Abide Financial Ltd United Kingdom Abide Financial Repository Limited United Kingdom Astley & Pearce Limited United Kingdom Board of Trade of the City of Chicago, Inc. Delaware BrokerTec Americas LLC Delaware BrokerTec Europe Limited United Kingdom Broke

CME / CME Group, Inc. DEFA14A - - DEFA14A

DEFA14A 1 d574756ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEUDLE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ P

CME / CME Group, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: CME Group Inc Title of Class of Securities: Common Stock CUSIP Number: 12572Q105 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule

- more -

Exhibit 99.1 Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Fourth-Quarter and Full-Year 2019 Financial Results CHICAGO, February 12, 2020 - CME Group Inc. (NASDAQ: CME) today reported financial results for the fourth quarter and full year

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 12, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

CME / CME Group, Inc. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEUDLE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 5, 2020 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No

Fifteenth Amended and Restated Bylaws of CME Group Inc. (incorporated by reference to Exhibit 3.1 to CME Group Inc.’s Current Report on Form 8-K, filed with the SEC on February 7, 2020).

EX-3.1 Exhibit 3.1 FIFTEENTH AMENDED AND RESTATED BYLAWS OF CME GROUP INC. Approved as of February 5, 2020 ARTICLE I SHAREHOLDERS’ MEETINGS Section 1.1 Annual Meetings. (a) The annual meetings of shareholders shall be held on such date, at such time and at such place, either within or without the state of Delaware, as shall be designated from time to time by the Board of Directors and stated in th

# # #

EX-99.1 Exhibit 99.1 Media Contacts Investor Contact Chris Grams, 312.813.5122 John Peschier, 312.930.8491 Laurie Bischel, 312.292.1937 CME-G [email protected] www.cmegroup.com/media-room.html FOR IMMEDIATE RELEASE CME Group Announces Bryan Durkin to Step Down as President CHICAGO, February 6, 2020 – CME Group today announced that Bryan T. Durkin will step down as President in May of this year. At

CME / CME Group, Inc. CORRESP - -

CORRESP 1 filename1.htm December 19, 2019 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 ATTN: Mr. Robert Klein Mr. Hugh West, Branch Chief RE: CME Group, Inc. Form 10-K for the Fiscal Year Ended December 31, 2018 Filed February 28, 2019 File No. 001-31553 Dear Gentlemen: This letter sets forth the responses of C

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 16, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File N

Amended and Restated Agreement, effective as of December 16, 2019, by and between CME Group Inc. and Terrence A. Duffy (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 8-K, filed with the SEC on December 18, 2019).

EX-10.1 2 d851626dex101.htm EX-10.1 Exhibit 10.1 AMENDED AND RESTATED AGREEMENT THIS AMENDED AND RESTATED AGREEMENT, effective as of December 16, 2019 (the “Restatement Effective Date”) by and between CME Group Inc. (“Employer” or “CME”), a Delaware corporation, having its principal place of business at 20 South Wacker Drive, Chicago, Illinois, and Terrence A. Duffy (“Executive”). R E C I T A L S:

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 12, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (

Media Contacts Anita Liskey, 312.466.4613 Laurie Bischel, 312.648.8698 [email protected] www.cmegroup.mediaroom.com Investor Contact John Peschier, 312.930.8491 CME-G

EX-99.1 Exhibit 99.1 Media Contacts Anita Liskey, 312.466.4613 Laurie Bischel, 312.648.8698 [email protected] www.cmegroup.mediaroom.com Investor Contact John Peschier, 312.930.8491 CME-G FOR IMMEDIATE RELEASE CME Group Announces Resignation of Alex J. Pollock from Its Board of Directors to Accept Senior Position with the U.S. Treasury CHICAGO, November 12, 2019 – CME Group today announced that Al

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n

- more -

Exhibit 99.1 Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Third-Quarter 2019 Financial Results CHICAGO, October 30, 2019 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2019. The company reported

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) October 30, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (I

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) August 7, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number

Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of U.S. Bank National Association, as trustee under the subordinated indenture.**

EX-25.2 Exhibit 25.2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 31-0841368 I.R.S. Employer

Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of U.S. Bank National Association, as trustee under the indenture.**

EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 31-0841368 I.R.S. Employer

CME / CME Group, Inc. S-3ASR - - S-3ASR

S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 2, 2019 Registration No.

- more -

Exhibit 99.1 Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Second-Quarter 2019 Financial Results CHICAGO, July 31, 2019 - CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2019. The company reported r

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 31, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS

Submission of Matters to a Vote of Security Holders

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 8, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IR

Quarterly Report - FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 - OR - ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 1, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction of Incorporation) (Commission File No.) (IR

Amendment No. 2 to Credit Agreement and Bank Joinder Agreement, dated as of May 1, 2019, between Chicago Mercantile Exchange Inc., certain lenders, Bank of America, N.A., as Administrative Agent and Citibank N.A. as Collateral Agent and Collateral Monitoring Agent. The Amended Credit Agreement, as amended as of May 1, 2019, between Chicago Mercantile Exchange Inc., certain lenders, Bank of America, N.A., as Administrative Agent and Citibank N.A. as Collateral Agent and Collateral Monitoring Agent (incorporated by reference to Exhibit 10.1 to CME Group Inc.'s Form 8-K, filed with the SEC on May 6, 2019

EX-10.1 Exhibit 10.1 EXECUTION VERSION AMENDMENT NO. 2 TO CREDIT AGREEMENT This AMENDMENT NO. 2 TO CREDIT AGREEMENT (this “Amendment”) dated as of May 1, 2019, is among CHICAGO MERCANTILE EXCHANGE INC., a Delaware corporation (the “Company”), BANK OF AMERICA, N.A., in its capacity as administrative agent for the Banks (as defined in the Credit Agreement described below) (in such capacity, the “Adm

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a8-kearningsrelease3312019.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) May 1, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdiction o

- more -

Exhibit 99.1 Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports First-Quarter 2019 Financial Results CHICAGO, May 1, 2019 - CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2019. The company reported reven

CME / CME Group, Inc. DEFA14A

DEFA14A 1 d928932ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEUDLE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ P

CME / CME Group, Inc. DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEUDLE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

CME / CME Group, Inc. DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

CME / CME Group, Inc. DEF 14A

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

List of Subsidiaries of CME Group Inc.

Exhibit 21.1 CME Group Subsidiaries Name of Subsidiary* Jurisdiction of Incorporation or Organization Abide Financial DRSP Limited United Kingdom Abide Financial Ltd United Kingdom Abide Financial Repository Limited United Kingdom Astley & Pearce Limited United Kingdom Board of Trade of the City of Chicago, Inc. Delaware BrokerTec Americas LLC Delaware BrokerTec Europe Limited United Kingdom Broke

Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-31553 CME GROUP INC. (Exact name of registrant as speci

CME / CME Group, Inc. CORRESP - -

CORRESP 1 filename1.htm February 28, 2019 VIA EDGAR TRANSMISSION Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: Filing of CME Group Inc. Annual Report on Form 10-K for the year ended December 31, 2018 Ladies and Gentlemen: On behalf of CME Group Inc., a Delaware corporation (the “Company”), transmitted herewith for filing is the Company’s Annual Report on Form

- more -

Exhibit 99.1 Media contact Investor contact Anita Liskey, 312.466.4613 John Peschier, 312.930.8491 Chris Grams, 312.930.3435 CME-G [email protected] www.cmegroup.mediaroom.com FOR IMMEDIATE RELEASE CME Group Inc. Reports Fourth-Quarter and Full-Year 2018 Financial Results CHICAGO, February 14, 2019 - CME Group Inc. (NASDAQ: CME) today reported financial results for the fourth quarter and full year

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a8-kearningsrelease12312018.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 14, 2019 CME GROUP INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-31553 36-4459170 (State or Other Jurisdi